ISTEBLIX Canadian Trademark Information

On Tuesday, April 8, 2003, a canadian trademark registration was filed for ISTEBLIX by Agouron Pharmaceuticals, Inc. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1173975. The current status of this trademark filing is Application withdrawn. The correspondent listed for ISTEBLIX is GOWLING WLG (CANADA) LLP of *********, **********, ***** **** The ISTEBLIX trademark is filed in the description of Pharmaceutical prepations for the treatment of cardiovascular disease; central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, and smoking habits or addictions; neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy; genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; gastrointestinal diseases and disorders; musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; allergies; diabetes; hypertension, erectile dysfunction; sexual dysfunction; cancer; migraines; pain, namely headaches, migraines, back pain, pain from burns, neuropathic pain; obesity; inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; the respiratory system; infectious diseases, namely respiratory infections, eye infections; immunological diseases and disorders, namely autoimmune diseases, immunological deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS); viral diseases and disorders, namely herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); stroke; carpal tunnel syndrome; varicose veins; osteoporosis; arthritis; multiple sclerosis; yeast infections; prostate disorders; and pulmonary disorders; pharmaceutical preparations for use in oncology; dermatology, namely dermatitis, skin pigmentation diseases; ophthalmology; ocular disorders; gastroenterology; and gynecoloy; pharmaceutical preparations, namely cholesterol preparations, namely preparations to lower cholesterol; smoking cessation preparations; tissue and skin repair preparations; acne medication; allergy medication; antacids, anthelmintics; antiarrhythmics; antibiotics; anticoagulants; anticonvulsants; antiemetics; antiflatulants; antihistamines; antihypertensives; anti-infectives; anti-inflammatories; antiparasitics; antibacterials; antifungals; antivirals; burn relief medication; calcium channel blockers; central nervous system depressants; central nervous system stimulants; cough treatment medication; diarrhea medication; gastrointestinal medication; glaucoma agents; hydrocortisone; hypnotic agents; sedatives; and ophthalmic preparations. .